Status:
UNKNOWN
Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients
Lead Sponsor:
Prince of Wales Hospital, Shatin, Hong Kong
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation is a clinically significant cardiac arrhythmia that increases the risk of stroke by 3 to 4 times. Oral anticoagulation has been shown to mitigate stroke risk by two-thirds among pa...
Eligibility Criteria
Inclusion
- diagnosis as atrial fibrillation
- aged ≧18 years
- able to given consent
Exclusion
- Unable/unwillingness to sign informed consent to study
- mechanical heart valve
- moderate-to-severe mitral stenosis
- Transient atrial fibrillation from reversible cause (e.g., during respiratory tract infection or bronchospasm)
- pregnancy
- hospitalization within 1 month prior to inclusion in the study.
Key Trial Info
Start Date :
August 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 23 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04062071
Start Date
August 23 2019
End Date
March 23 2020
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LIAO, Jiawei
Hong Kong, Hong Kong